Structure Therapeutics

About:

Structure Therapeutics specializes in the discovery and development of drugs against a type of targets called GPCR.

Website: https://structuretx.com/

Twitter/X: StructureTx

Top Investors: Schrödinger, Qiming Venture Partners, F-Prime Capital, Cormorant Asset Management, HongShan

Description:

Structure Therapeutics creates life-changing medicines for patients using advanced computational and structure-based technology. Our platform combines the latest advancements in computational chemistry, visualization of molecular interactions, and data integration to design orally available, superior medicines that overcome current limitations in biologic and peptide drugs. We are advancing our clinical-stage pipeline of differentiated, efficacious and safe treatments focused on chronic diseases with high unmet need, including cardiovascular, metabolic and pulmonary conditions. At Structure, our team’s deep experience with complex biological targets and mechanisms, structure-based drug design, and global drug discovery and development enables our bold vision: to design and develop world-class medicines with tremendous patient impact and broad commercial opportunity.